|
Momentum Trade #1
Moderna
MRNA
Momentum score +13.79
MACD: rising
Healthcare · Biotechnology
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as intismeran autogene, cancer antigen therapy, t-cell engager, and cell therapy enhancer; and rare disease products, including propionic and methylmalonic acidemia, and cystic fibrosis. It has strategic alliances and collaborations with Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; immatics N.V.; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Price last 6 months + analyst targets (L / M / H)
Analyst ratings · 19 analysts
Strong Buy 4% · 1 Buy 13% · 3 Hold 65% · 15 Sell 9% · 2 Strong Sell 9% · 2 Price targets
Low $45 Mean $145 High $260 Upside -42.8% Examples of possible option trades
Option trade — Buy Call
Call $250.00 · exp 04/12/2026
−$2783.00
When to use? If you expect a big move up before the option expires.
Max profitUnlimited The higher the stock goes, the more you make. Max loss$2,783 The premium you paid. Breakeven stock price$277.83 $250 strike + $27.83 premium. Option trade — Sell Put
Put $255.00 · exp 04/12/2026
+$2565.00
When to use? If you expect the stock to hold above the strike price, or you would be happy to buy at a lower price.
Max profit$2,565 The premium received, if the stock stays above $255. Max loss$22,935 If the stock falls to $0 (100 × $255, minus the $2,565 premium). Breakeven stock price$229.35 $255 strike − $25.65 premium. Option trade — Bull Call Spread
Call $250.00 · exp 04/12/2026
−$2783.00
Call $275.00 · exp 04/12/2026
+$1762.00
When to use? If you expect a moderate rise, not a huge one.
Max profit$1,479 If the stock finishes at or above $275 ($2,500 price spread − $1,021 net cost). Max loss$1,021 The net cost, if the stock stays below $250. Breakeven stock price$260.21 $250 buy strike + $10.21 net cost. |
||
|
Momentum Trade #2
Viatris
VTRS
Momentum score +1.06
MACD: rising
Healthcare · Drug Manufacturers - Specialty & Generic
Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex generic drugs, and biosimilars. It also provides drugs in various therapeutic areas covering various noncommunicable and infectious diseases, including cardiovascular, CNS and anesthesia, dermatology, diabetes and metabolism, eye care, gastroenterology, immunology, oncology, and respiratory and allergy, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. In addition, the company offers medicines in the form of oral solid doses, injectables, and complex dosage forms to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. It distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies under the Lyrica, Lipitor, Celebrex, Viagra, Creon, Influvac, Wixela Inhub, EpiPen Auto-Injector, Fraxiparine, Yupelri, Norvasc, Amitiza, Effexor, Lipacreon, Zoloft, Xalabrands, Dymista, Xanax, and Breyna brands. The company has collaboration agreements with Mapi Pharma Ltd. to develop and commercialize long-acting glatiramer acetate depot products and additional products; Revance Therapeutics, Inc. to develop, manufacture, and commercialize a biosimilar to the branded biologic product, BOTOX; and Theravance Biopharma, Inc. to develop and commercialize revefenacin. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.
Price last 6 months + analyst targets (L / M / H)
Analyst ratings · 10 analysts
Strong Buy 8% · 1 Buy 50% · 6 Hold 33% · 4 Sell 0% · 0 Strong Sell 8% · 1 Price targets
Low $14 Mean $21 High $28 Upside +5.5% Examples of possible option trades
Option trade — Buy Call
Call $17.00 · exp 18/12/2026
−$295.00
When to use? If you expect a big move up before the option expires.
Max profitUnlimited The higher the stock goes, the more you make. Max loss$295 The premium you paid. Breakeven stock price$19.95 $17 strike + $2.95 premium. Option trade — Sell Put
Put $19.00 · exp 18/12/2026
+$55.00
When to use? If you expect the stock to hold above the strike price, or you would be happy to buy at a lower price.
Max profit$55 The premium received, if the stock stays above $19. Max loss$1,845 If the stock falls to $0 (100 × $19, minus the $55 premium). Breakeven stock price$18.45 $19 strike − $0.55 premium. Option trade — Bull Call Spread
Call $17.00 · exp 18/12/2026
−$295.00
Call $22.00 · exp 18/12/2026
+$15.00
When to use? If you expect a moderate rise, not a huge one.
Max profit$220 If the stock finishes at or above $22 ($500 price spread − $280 net cost). Max loss$280 The net cost, if the stock stays below $17. Breakeven stock price$19.80 $17 buy strike + $2.80 net cost. |
||
|
Momentum Trade #3
Humana
HUM
Momentum score +0.86
MACD: rising
Healthcare · Healthcare Plans
Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers. Its CenterWell segment operates full-service, value-based senior focused primary care centers under the Conviva Senior Primary Care and CenterWell Senior Primary Care brands; a management services organization; CenterWell Home Health, a home health provider; and OneHome, which manages post-acute patient needs, as well as provides pharmacy and hospice solutions. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Price last 6 months + analyst targets (L / M / H)
Analyst ratings · 24 analysts
Strong Buy 12% · 3 Buy 50% · 13 Hold 35% · 9 Sell 4% · 1 Strong Sell 0% · 0 Price targets
Low $280 Mean $465 High $596 Upside +7.2% Examples of possible option trades
Option trade — Buy Call
Call $430.00 · exp 04/12/2026
−$2545.00
When to use? If you expect a big move up before the option expires.
Max profitUnlimited The higher the stock goes, the more you make. Max loss$2,545 The premium you paid. Breakeven stock price$455.45 $430 strike + $25.45 premium. Option trade — Sell Put
Put $440.00 · exp 04/12/2026
+$2405.00
When to use? If you expect the stock to hold above the strike price, or you would be happy to buy at a lower price.
Max profit$2,405 The premium received, if the stock stays above $440. Max loss$41,595 If the stock falls to $0 (100 × $440, minus the $2,405 premium). Breakeven stock price$415.95 $440 strike − $24.05 premium. Option trade — Bull Call Spread
Call $430.00 · exp 04/12/2026
−$2545.00
Call $490.00 · exp 04/12/2026
+$560.00
When to use? If you expect a moderate rise, not a huge one.
Max profit$4,015 If the stock finishes at or above $490 ($6,000 price spread − $1,985 net cost). Max loss$1,985 The net cost, if the stock stays below $430. Breakeven stock price$449.85 $430 buy strike + $19.85 net cost. |
||
|
Momentum Trade #4
Target
TGT
Momentum score +0.69
MACD: rising
Consumer Defensive · Discount Stores
Target Corporation operates as a general merchandise retailer in the United States. It offers apparel for women, men, young adults, kids, toddlers, and babies, as well as jewelry, accessories, and shoes; and beauty products, such as skin and bath care, cosmetics, hair care, oral care, deodorant, and shaving products. The company also provides food and beverage products comprising dry and perishable grocery, including snacks, candy, beverages, deli, bakery, meat, produce, and food service; electronics which includes video games and consoles, toys, sporting goods, entertainment, and luggage; bed and bath, home décor, school/office supplies, storage, small appliances, kitchenware, greeting cards, party supplies, furniture, lighting, home improvement, and seasonal merchandise; and household essentials, such as household cleaning, paper products, over-the-counter healthcare, vitamins and supplements, baby gear, and pet supplies. In addition, it sells merchandise through periodic design and creative partnerships, and shop-in-shop experience; and in-store amenities. The company sells its products through its stores; and digital channels, including Target.com. Target Corporation was incorporated in 1902 and is headquartered in Minneapolis, Minnesota.
Price last 6 months + analyst targets (L / M / H)
Analyst ratings · 34 analysts
Strong Buy 5% · 2 Buy 29% · 11 Hold 55% · 21 Sell 0% · 0 Strong Sell 11% · 4 Price targets
Low $128 Mean $163 High $190 Upside +3.1% Examples of possible option trades
Option trade — Buy Call
Call $155.00 · exp 04/12/2026
−$973.00
When to use? If you expect a big move up before the option expires.
Max profitUnlimited The higher the stock goes, the more you make. Max loss$973 The premium you paid. Breakeven stock price$164.73 $155 strike + $9.73 premium. Option trade — Sell Put
Put $155.00 · exp 04/12/2026
+$753.00
When to use? If you expect the stock to hold above the strike price, or you would be happy to buy at a lower price.
Max profit$753 The premium received, if the stock stays above $155. Max loss$14,747 If the stock falls to $0 (100 × $155, minus the $753 premium). Breakeven stock price$147.47 $155 strike − $7.53 premium. Option trade — Bull Call Spread
Call $155.00 · exp 04/12/2026
−$973.00
Call $175.00 · exp 04/12/2026
+$254.00
When to use? If you expect a moderate rise, not a huge one.
Max profit$1,281 If the stock finishes at or above $175 ($2,000 price spread − $719 net cost). Max loss$719 The net cost, if the stock stays below $155. Breakeven stock price$162.19 $155 buy strike + $7.19 net cost. |
||
|
Momentum Trade #5
Keurig Dr Pepper
KDP
Momentum score +0.59
MACD: rising
Consumer Defensive · Beverages - Non-Alcoholic
Keurig Dr Pepper Inc. owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. The company operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. It manufactures and distributes branded concentrates, syrup, and finished beverages, as well as sales of owned brands and third-party brands; tea, cocoa, and other products; and offers finished goods relating to K-Cup pods, single serve brewers, specialty coffee, and ready to drink coffee products. The company offers its products under the Dr Pepper, Canada Dry, Mott's, A&W, Peñafiel, GHOST, Snapple, 7UP, Green Mountain Coffee Roasters, Clamato, Core Hydration, The Original Donut Shop, Sunkist soda, Squirt, C4 Energy, Hawaiian Punch, Electrolit, Bloom, Bai, Evian, Yoo-Hoo, Vita Coco, Big Red, RC Cola, Crush, McCafé, Tim Hortons, Van Houtte, Celestial Seasonings, Bigelow, Starbucks, Dunkin', Folgers, Peet's, and Swiss Miss brands, as well as other partner and private label brands. It markets and sells its products to supermarkets, mass merchandisers, club stores, e-commerce retailers, office superstores, vending machines, fountains, grocery and drug stores, convenience stores, and other small outlets; and directly to consumers through Keurig.com website. Keurig Dr Pepper Inc. was founded in 1981 and is headquartered in Frisco, Texas.
Price last 6 months + analyst targets (L / M / H)
Analyst ratings · 17 analysts
Strong Buy 28% · 5 Buy 44% · 8 Hold 28% · 5 Sell 0% · 0 Strong Sell 0% · 0 Price targets
Low $32 Mean $38 High $42 Upside +3.8% Examples of possible option trades
Option trade — Buy Call
Call $35.00 · exp 18/12/2026
−$247.00
When to use? If you expect a big move up before the option expires.
Max profitUnlimited The higher the stock goes, the more you make. Max loss$247 The premium you paid. Breakeven stock price$37.47 $35 strike + $2.47 premium. Option trade — Sell Put
Put $37.00 · exp 18/12/2026
+$145.00
When to use? If you expect the stock to hold above the strike price, or you would be happy to buy at a lower price.
Max profit$145 The premium received, if the stock stays above $37. Max loss$3,555 If the stock falls to $0 (100 × $37, minus the $145 premium). Breakeven stock price$35.55 $37 strike − $1.45 premium. Option trade — Bull Call Spread
Call $35.00 · exp 18/12/2026
−$247.00
Call $40.00 · exp 18/12/2026
+$33.00
When to use? If you expect a moderate rise, not a huge one.
Max profit$286 If the stock finishes at or above $40 ($500 price spread − $214 net cost). Max loss$214 The net cost, if the stock stays below $35. Breakeven stock price$37.14 $35 buy strike + $2.14 net cost. |
||
|
Momentum Trade #6
Cboe Global Markets
CBOE
Momentum score +0.54
MACD: rising
Financial Services · Financial Data & Stock Exchanges
Cboe Global Markets, Inc., through its subsidiaries, operates as a derivatives and securities exchange network that delivers trading, clearing, and investment solutions in the United States and internationally. It operates through five segments: Options, North American Equities, Europe and Asia Pacific, Futures, and Global FX. The Options segment includes options on market indices, stocks of individual corporations, and exchange-traded products (ETPs), such as exchange-traded funds (ETFs) and exchange-traded notes (ETNs). This segment also offers trading in listed options through a single system. The North American Equities segment comprises U.S. equities and ETP transaction services. This segment also includes listing services on Cboe Canada, ETP listings on BZX, the Cboe Global Markets, Inc. common stock listing, and applicable market data. The Europe and Asia Pacific segment provides pan-European derivatives transaction services; ETPs, including exchange-traded funds, exchange-traded notes, and exchange-traded commodities; international depository receipts; and an ETP listings business on regulated markets and clearing activities, as well as equities services. The Futures segment offers transaction services, including trading in VIX futures and other futures products, the licensing of proprietary market data, and access and capacity services. The Global FX segment provides institutional foreign exchange (FX) trading and non-deliverable forward FX transaction services. The company also provides trading solutions and products in multiple asset classes, including equities, derivatives, and FX across North America, Europe, and Asia Pacific. It has strategic relationships with S&P Dow Jones Indices, LLC; Frank Russell Company; and FTSE International Limited. The company was formerly known as CBOE Holdings, Inc. and changed its name to Cboe Global Markets, Inc. in October 2017. Cboe Global Markets, Inc. was founded in 1973 and is headquartered in Chicago, Illinois.
Price last 6 months + analyst targets (L / M / H)
Analyst ratings · 15 analysts
Strong Buy 17% · 3 Buy 11% · 2 Hold 67% · 12 Sell 0% · 0 Strong Sell 6% · 1 Price targets
Low $299 Mean $354 High $461 Upside +0.2% Examples of possible option trades
Option trade — Buy Call
Call $350.00 · exp 04/12/2026
−$1605.00
When to use? If you expect a big move up before the option expires.
Max profitUnlimited The higher the stock goes, the more you make. Max loss$1,605 The premium you paid. Breakeven stock price$366.05 $350 strike + $16.05 premium. Option trade — Sell Put
Put $325.00 · exp 04/12/2026
+$408.00
When to use? If you expect the stock to hold above the strike price, or you would be happy to buy at a lower price.
Max profit$408 The premium received, if the stock stays above $325. Max loss$32,092 If the stock falls to $0 (100 × $325, minus the $408 premium). Breakeven stock price$320.92 $325 strike − $4.08 premium. Option trade — Bull Call Spread
Call $350.00 · exp 04/12/2026
−$1605.00
Call $390.00 · exp 04/12/2026
+$282.00
When to use? If you expect a moderate rise, not a huge one.
Max profit$2,677 If the stock finishes at or above $390 ($4,000 price spread − $1,323 net cost). Max loss$1,323 The net cost, if the stock stays below $350. Breakeven stock price$363.23 $350 buy strike + $13.23 net cost. |
||
|
Momentum Trade #7
Becton, Dickinson and
BDX
Momentum score +0.52
MACD: rising
Healthcare · Medical Instruments & Supplies
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
Price last 6 months + analyst targets (L / M / H)
Analyst ratings · 14 analysts
Strong Buy 6% · 1 Buy 44% · 7 Hold 44% · 7 Sell 0% · 0 Strong Sell 6% · 1 Price targets
Low $165 Mean $196 High $225 Upside -7.7% Examples of possible option trades
Option trade — Buy Call
Call $210.00 · exp 18/12/2026
−$950.00
When to use? If you expect a big move up before the option expires.
Max profitUnlimited The higher the stock goes, the more you make. Max loss$950 The premium you paid. Breakeven stock price$219.50 $210 strike + $9.50 premium. Option trade — Sell Put
Put $210.00 · exp 18/12/2026
+$2290.00
When to use? If you expect the stock to hold above the strike price, or you would be happy to buy at a lower price.
Max profit$2,290 The premium received, if the stock stays above $210. Max loss$18,710 If the stock falls to $0 (100 × $210, minus the $2,290 premium). Breakeven stock price$187.10 $210 strike − $22.90 premium. Option trade — Bull Call Spread
Call $210.00 · exp 18/12/2026
−$950.00
Call $230.00 · exp 18/12/2026
+$225.00
When to use? If you expect a moderate rise, not a huge one.
Max profit$1,275 If the stock finishes at or above $230 ($2,000 price spread − $725 net cost). Max loss$725 The net cost, if the stock stays below $210. Breakeven stock price$217.25 $210 buy strike + $7.25 net cost. |
||
|
Momentum Trade #8
Estee Lauder Companies, Inc. (T
EL
Momentum score +0.48
MACD: rising
Consumer Defensive · Household & Personal Products
The Estée Lauder Companies Inc. manufactures, markets, and sells skin care, makeup, fragrance, and hair care products worldwide. The company provides skin care products, including moisturizers, serums, cleansers, toners, eye care, body care, exfoliators, acne care and oil correctors, facial masks, and sun care products; and makeup products, such as foundations, powders, concealers and setting sprays, lipsticks, lip liners and lip glosses, mascaras, and eyeshadows and eyeliners, as well as compacts, brushes, and other makeup tools. It also offers fragrance products in various forms comprising parfum, eau de parfum, eau de toilette, eau de cologne, and body spray, as well as lotions, creams, powders, candles and soaps; and hair care products, including shampoos, conditioners, styling products, treatment, finishing sprays, and hair color products, as well as sells ancillary products and services. The company provides its products under the La Mer, Jo Malone London, TOM FORD, AERIN Beauty, Le Labo, Editions de Parfums Frédéric Malle, KILIAN PARIS, BALMAIN Beauty, Estée Lauder, Clinique, M·A·C, The Ordinary, Aveda, Bobbi Brown Cosmetics, Too Faced, Dr.Jart+, Bumble and bumble, Smashbox, Darphin Paris, Lab Series, Avestan, Loopha, Origins, NIOD, Aramis, and GLAMGLOW brands. It sells its products through department stores, duty-free retailers, specialty multi retailers, online pure players, upscale perfumeries and pharmacies, and top-tier salons and spas, as well as direct-to-consumer businesses across freestanding stores, and brand websites and third-party online platforms. The Estée Lauder Companies Inc. was founded in 1946 and is based in New York, New York.
Price last 6 months + analyst targets (L / M / H)
Analyst ratings · 27 analysts
Strong Buy 20% · 6 Buy 30% · 9 Hold 47% · 14 Sell 3% · 1 Strong Sell 0% · 0 Price targets
Low $70 Mean $114 High $129 Upside +3.6% Examples of possible option trades
Option trade — Buy Call
Call $110.00 · exp 04/12/2026
−$410.00
When to use? If you expect a big move up before the option expires.
Max profitUnlimited The higher the stock goes, the more you make. Max loss$410 The premium you paid. Breakeven stock price$114.10 $110 strike + $4.10 premium. Option trade — Sell Put
Put $109.00 · exp 04/12/2026
+$355.00
When to use? If you expect the stock to hold above the strike price, or you would be happy to buy at a lower price.
Max profit$355 The premium received, if the stock stays above $109. Max loss$10,545 If the stock falls to $0 (100 × $109, minus the $355 premium). Breakeven stock price$105.45 $109 strike − $3.55 premium. Option trade — Bull Call Spread
Call $110.00 · exp 04/12/2026
−$410.00
Call $120.00 · exp 04/12/2026
+$148.00
When to use? If you expect a moderate rise, not a huge one.
Max profit$738 If the stock finishes at or above $120 ($1,000 price spread − $262 net cost). Max loss$262 The net cost, if the stock stays below $110. Breakeven stock price$112.62 $110 buy strike + $2.62 net cost. |
||
|
Momentum Trade #9
DaVita
DVA
Momentum score +0.44
MACD: rising
Healthcare · Medical Care Facilities
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Price last 6 months + analyst targets (L / M / H)
Analyst ratings · 7 analysts
Strong Buy 0% · 0 Buy 38% · 3 Hold 50% · 4 Sell 0% · 0 Strong Sell 12% · 1 Price targets
Low $165 Mean $222 High $287 Upside +16.2% Examples of possible option trades
Option trade — Buy Call
Call $190.00 · exp 18/12/2026
−$1035.00
When to use? If you expect a big move up before the option expires.
Max profitUnlimited The higher the stock goes, the more you make. Max loss$1,035 The premium you paid. Breakeven stock price$200.35 $190 strike + $10.35 premium. Option trade — Sell Put
Put $190.00 · exp 18/12/2026
+$855.00
When to use? If you expect the stock to hold above the strike price, or you would be happy to buy at a lower price.
Max profit$855 The premium received, if the stock stays above $190. Max loss$18,145 If the stock falls to $0 (100 × $190, minus the $855 premium). Breakeven stock price$181.45 $190 strike − $8.55 premium. Option trade — Bull Call Spread
Call $190.00 · exp 18/12/2026
−$1035.00
Call $210.00 · exp 18/12/2026
+$310.00
When to use? If you expect a moderate rise, not a huge one.
Max profit$1,275 If the stock finishes at or above $210 ($2,000 price spread − $725 net cost). Max loss$725 The net cost, if the stock stays below $190. Breakeven stock price$197.25 $190 buy strike + $7.25 net cost. |
||
|
Momentum Trade #10
Stanley Black & Decker
SWK
Momentum score +0.42
MACD: rising
Industrials · Tools & Accessories
Stanley Black & Decker, Inc. provides hand tools, power tools, outdoor products, and related accessories in the United States, Canada, Other Americas, Europe, and Asia. Its Tools & Outdoor segment offers professional grade corded and cordless electric power tools and equipment, including drills, impact wrenches and drivers, grinders, saws, routers, concrete prep and placement tools, and sanders; pneumatic tools and fasteners; corded and cordless electric power tools; household power tools, hand-held vacuums, and small appliances; leveling and layout tools, planes, hammers, demolition tools, clamps, vises, knives, saws, chisels, and industrial and automotive tools; drill, screwdriver, router bits, abrasives, saw blades, and threading products; tool boxes, sawhorses, medical cabinets, and engineered storage solutions; and electric and gas-powered lawn and garden products. This segment sells its products under the DEWALT, CRAFTSMAN, CUB CADET, STANLEY, BLACK+DECKER, and HUSTLER brands through retailers, third-party distributors, independent dealers, and a direct sales force. Its Industrial segment provides threaded fasteners, blind rivets and tools, blind inserts and tools, drawn arc weld studs and systems, engineered plastic and mechanical fasteners, self-piercing riveting systems, precision nut running systems, micro fasteners, high-strength structural fasteners, axel swage, latches, heat shields, pins, couplings, fitting, and other engineered products. This segment sells its products through direct sales force and third-party distributors to the automotive, manufacturing, electronics, construction, aerospace, and other industries. Stanley Black & Decker, Inc. has a strategic partnership with I4F Licensing Nv. The company was formerly known as The Stanley Works and changed its name to Stanley Black & Decker, Inc. in March 2010. The company was founded in 1843 and is headquartered in New Britain, Connecticut.
Price last 6 months + analyst targets (L / M / H)
Analyst ratings · 11 analysts
Strong Buy 0% · 0 Buy 27% · 4 Hold 73% · 11 Sell 0% · 0 Strong Sell 0% · 0 Price targets
Low $90 Mean $105 High $140 Upside -8.9% Examples of possible option trades
Option trade — Buy Call
Call $110.00 · exp 18/12/2026
−$830.00
When to use? If you expect a big move up before the option expires.
Max profitUnlimited The higher the stock goes, the more you make. Max loss$830 The premium you paid. Breakeven stock price$118.30 $110 strike + $8.30 premium. Option trade — Sell Put
Put $110.00 · exp 18/12/2026
+$340.00
When to use? If you expect the stock to hold above the strike price, or you would be happy to buy at a lower price.
Max profit$340 The premium received, if the stock stays above $110. Max loss$10,660 If the stock falls to $0 (100 × $110, minus the $340 premium). Breakeven stock price$106.60 $110 strike − $3.40 premium. Option trade — Bull Call Spread
Call $110.00 · exp 18/12/2026
−$830.00
Call $125.00 · exp 18/12/2026
+$202.00
When to use? If you expect a moderate rise, not a huge one.
Max profit$872 If the stock finishes at or above $125 ($1,500 price spread − $628 net cost). Max loss$628 The net cost, if the stock stays below $110. Breakeven stock price$116.28 $110 buy strike + $6.28 net cost. |
In the investment world, many try to outsmart the market by hunting for “cheap” or beaten-down stocks. The hard reality is that what is cheap often stays cheap for a very long time.
These stocks are not selected on gut feeling, but through a standardised Z-score that isolates purely the strongest risers with the most stable momentum.
Momentum forces you to follow the market as it is, not as you think it should be. That makes it not only rational, but simply the most efficient trading strategy.
Imagine opening a tool each morning that hands you a shortlist of stocks already moving strongly upward, so you do not have to spend hours scanning the market yourself. That is exactly what this tool gives you: the strongest momentum stocks of the moment, ranked and ready. Instead of guessing which stocks are “hot” right now, you save time and get a data-driven head start. All you need to do is pick a stock and read the corresponding option examples.
Next to each stock you will find a momentum score and a MACD signal — two numbers that instantly tell you how strong and how fresh the upward move really is. The momentum score ranks how strongly a stock is trending compared to others, so the higher the number, the more it stands out. The MACD (Moving Average Convergence Divergence) is a technical indicator, and when you see it marked “rising”, it tells you the momentum may still have room to run.
This widget gives you a short, plain-language summary of what the company does. Below that, you get a six-month price chart. The chart also plots analyst price targets — low, mean and high — giving you an instant comparison between today’s price and where experts think it could go. There is no need to jump between websites.
You do not have to rely on your own judgement alone — professional analysts who follow each stock closely publish ratings, from “Strong Buy” to “Strong Sell”, and this tool shows you exactly how many fall into each category. You also get their price targets: the low, mean and high estimates for where the stock could trade in the future. The “upside” figure gives you, in a single number, how far today’s price sits from the average analyst target — an easy way to judge whether professionals still see room for growth. This is not a guarantee of future performance, but it is a valuable second opinion you get for free, right alongside the stock’s momentum.
Before you pick your option strategy, read this compact overview. A call option gives you the right, but not the obligation, to buy a stock at a fixed price (the “strike”) before a set date — you buy a call when you expect the price to rise, since it lets you benefit from the upside without having to buy the shares outright. A put option gives someone the right to sell a stock to you at a fixed price — when you sell a put, you agree to buy the stock at that price if it falls there, and you are paid a premium upfront for taking on that obligation. A bull call spread combines two calls at once: you buy one call to benefit from a rise, and you sell another call at a higher strike to reduce your cost, which lowers both your risk and your potential reward compared with a plain call.
For every momentum stock you get three example option trades, each suited to a different market view, so you can pick the approach that matches your own expectations. They are examples, and you should reflect on the combination of parameters (strike, maturity and so on) that is optimal for your personal financial situation and risk preferences. Every example already has the numbers calculated for the current price and expiry date, so you can compare them side by side and choose the one that fits you best.
The Buy Call is the simplest for you: you pay a premium for the right to profit if the stock rises sharply, with unlimited upside potential. The Sell Put works differently — you receive a premium upfront in exchange for agreeing to buy the stock at a lower price if it falls, which suits you if you would be happy to own the stock anyway. The Bull Call Spread gives you a lower-cost, lower-risk way to profit from a moderate rise, since part of what you pay is offset by a premium you receive.
One of the most reassuring parts of this tool is that it calculates your maximum profit, your maximum loss and your breakeven price for every strategy, before you ever place an order. This means you always know in advance exactly how much you stand to gain, exactly how much you could lose, and exactly what price the stock needs to reach for you to come out even. As a beginner, this transparency removes much of the guesswork and anxiety that comes with options trading. Knowing your numbers upfront helps you build disciplined, confident investing habits from day one.
If you do not yet have an account, opening one is quick and easy. You can go from browsing this page to placing your first trade in just a few steps. Through FreeStoxx or a WH SelfInvest multi-market account, you get direct access to place the very trades shown in this tool, without switching platforms or re-entering the strategies elsewhere. Typing errors in options are quickly made. You will find the process straightforward, and support is there for you if you have questions along the way. There is no need to feel intimidated — thousands of everyday investors started exactly where you are now.
Once you have found a stock and strategy that match your outlook, placing an order is as simple as clicking the button right next to it — no need to search for the stock or option separately on another screen. Every example trade already has its strike price, expiry date and premium calculated for you, so the order button carries that information straight into your order ticket, ready for your final review. Just double-check the quantity and price before confirming. From there your order is submitted, and you have turned your idea into action in just a few clicks.